The NSCLC market is expanding due to rising global prevalence and advancements in targeted treatments. Key players like Merck, Roche, and AstraZeneca are driving progress with novel immunotherapies and precision medicines that enhance survival rates. Emerging biomarkers and combination therapies are further optimizing treatment strategies for improved patient outcomes.
View Full Report:
https://www.delveinsight.com/i....nfographics/non-smal
إعجاب
علق
شارك
